Prudential Financial’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Other funds holding RETA
Prudential Financial's RETA Position: Q3 2023 in Review
Prudential Financial sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 2,208 shares — an estimated $225K sold.
Prudential Financial first reported a position in RETA in Q2 2019 and held it in 6 quarters. The position peaked at $2.09M in Q1 2020. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.
- Prudential Financial reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Prudential Financial sold 2,208 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $225K.
- Prudential Financial first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2019 and held it in 6 quarters.
- Prudential Financial's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $2.09M in Q1 2020.
- 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.
Based on Prudential Financial's 13F filing for Q3 2023, filed 13 Nov 2023.